5681 |
7YMS |
FE_A |
9B5 Fab |
Coxsackievirus A16 (CVA16) viral particles capsid protein VP1 |
Coxsackievirus A16 |
EM |
2.9 | 10.1038/s41467-022-35575-w |
5682 |
7YOW |
HL_R |
NCV2SG48 Fab |
SARS-CoV-2 Omicron spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
3.3 | 10.1038/s42003-023-04782-6 |
5683 |
7YOW |
BA_C |
NCV2SG48 Fab |
SARS-CoV-2 Omicron spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
3.3 | 10.1038/s42003-023-04782-6 |
5684 |
7YQX |
HF_B |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 1) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.72 | 10.1016/j.chom.2022.09.018 |
5685 |
7YQX |
IG_A |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 1) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.72 | 10.1016/j.chom.2022.09.018 |
5686 |
7YQY |
HF_B |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 2) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.74 | 10.1016/j.chom.2022.09.018 |
5687 |
7YQY |
IG_A |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 2) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.74 | 10.1016/j.chom.2022.09.018 |
5688 |
7YQY |
JE_C |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 2) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.74 | 10.1016/j.chom.2022.09.018 |
5689 |
7YQZ |
IG_A |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 3) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.84 | 10.1016/j.chom.2022.09.018 |
5690 |
7YQZ |
JH_C |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (state 3) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.84 | 10.1016/j.chom.2022.09.018 |
5691 |
7YR0 |
CB_A |
S309 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein (local) |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.98 | 10.1016/j.chom.2022.09.018 |
5692 |
7YR1 |
HL_A |
XG2v024 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.62 | 10.1016/j.chom.2022.09.018 |
5693 |
7YR1 |
DF_B |
XG2v024 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.62 | 10.1016/j.chom.2022.09.018 |
5694 |
7YR1 |
EG_C |
XG2v024 Fab |
SARS-CoV-2 BA.2.75 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.62 | 10.1016/j.chom.2022.09.018 |
5695 |
7YRF |
FE_C |
8C4 Fab |
Coxsackievirus A16 capsids glycoprotein VP3 |
Coxsackievirus A16, Mus musculus |
EM |
2.91 | 10.1038/s41467-022-35575-w |
5696 |
7YRH |
FE_A |
9B5 Fab |
Coxsackievirus A16 capsids glycoprotein VP1 |
Coxsackievirus A16, Mus musculus |
EM |
3.35 | 10.1038/s41467-022-35575-w |
5697 |
7YRU |
HL_A |
Rm0443 Fab |
Human activin receptor-like kinase 2 (ALK2) |
Homo sapiens, Rattus norvegicus |
XRD |
2.6 | 10.1038/s41467-023-38746-5 |
5698 |
7YV7 |
FE_A |
9B5 Fab |
Coxsackievirus A16 (CVA16) empty particle VP1 |
Coxsackievirus A16, Mus musculus |
EM |
3.8 | 10.1038/s41467-022-35575-w |
5699 |
7YXU |
HL_A |
1618 Fab |
Human 4–1BB (CD137) |
Homo sapiens |
XRD |
2.31 | 10.1158/1535-7163.MCT-22-0395 |
5700 |
7YZ9 |
B_A |
NB4 VHH |
Mycobacterium tuberculosis adenylyl cyclase (AC) Rv1625c/Cya |
Mycobacterium tuberculosis H37Rv, Vicugna pacos |
XRD |
1.97 | 10.7554/eLife.77032 |